The state’s difficulties in the last year are indicative of wider industry problems during a time of market trepidation, as ...

While established US biotech hubs may still rule the roost, emerging competitors are looking to grab a larger slice of the ...

Federal funding cuts and threats to higher education are putting key ingredients of Boston’s recipe for biotech success in ...

Two years ago, Incendia Therapeutics, a biotechnology company specializing in cancer-related research, moved into Allston in a building along the Massachusetts Turnpike. Incendia, along with nearly a ...

The city is holding off its search for a developer and anchor tenant for its $1.6 billion life sciences campus in Kips Bay as ...

Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge's biotech scene so ...

More details have been revealed about a new biohealth technology hub that is projected to generate around 141,000 jobs over 10 years -- with most of those positions likely to be in supply-chain and ...

The majority of Americans do not live in a biotech hub. Yet 62 percent of all U.S. biopharma venture investment occurs in Massachusetts and California, according to Pitchbook, while 77 percent of ...

Speculative projects, a biotech downturn and economic conditions have brought challenges for commercial real estate. Local ...

It's the latest move to spur collaboration among Pentagon researchers and private industry as VelocityTX seeks to create a ...